Lemos Natália Emerim, de Almeida Brondani Letícia, Dieter Cristine, Rheinheimer Jakeline, Bouças Ana Paula, Bauermann Leitão Cristiane, Crispim Daisy, Bauer Andrea Carla
a Laboratory of Human Pancreatic Islet Biology , Endocrine Division, Hospital de Clínicas de Porto Alegre , Porto Alegre , Rio Grande do Sul , Brazil.
b Postgraduation Program in Endocrinology , Faculdade de Medicina, Universidade Federal do Rio Grande do Sul , Porto Alegre , Rio Grande do Sul , Brazil.
Islets. 2017 Sep 3;9(5):73-86. doi: 10.1080/19382014.2017.1335842. Epub 2017 Jul 5.
Pancreatic islet transplantation is an established treatment to restore insulin independence in type 1 diabetic patients. Its success rates have increased lately based on improvements in immunosuppressive therapies and on islet isolation and culture. It is known that the quality and quantity of viable transplanted islets are crucial for the achievement of insulin independence and some studies have shown that a significant number of islets are lost during culture time. Thus, in an effort to improve islet yield during culture period, researchers have tested a variety of additives in culture media as well as alternative culture devices, such as scaffolds. However, due to the use of different categories of additives or devices, it is difficult to draw a conclusion on the benefits of these strategies. Therefore, the aim of this systematic review was to summarize the results of studies that described the use of medium additives, scaffolds or extracellular matrix (ECM) components during human pancreatic islets culture. PubMed and Embase repositories were searched. Of 5083 articles retrieved, a total of 37 articles fulfilled the eligibility criteria and were included in the review. After data extraction, articles were grouped as follows: 1) "antiapoptotic/anti-inflammatory/antioxidant," 2) "hormone," 3) "sulphonylureas," 4) "serum supplements," and 5) "scaffolds or ECM components." The effects of the reviewed additives, ECM or scaffolds on islet viability, apoptosis and function (glucose-stimulated insulin secretion - GSIS) were heterogeneous, making any major conclusion hard to sustain. Overall, some "antiapoptotic/anti-inflammatory/antioxidant" additives decreased apoptosis and improved GSIS. Moreover, islet culture with ECM components or scaffolds increased GSIS. More studies are needed to define the real impact of these strategies in improving islet transplantation outcomes.
胰岛移植是一种已确立的用于恢复1型糖尿病患者胰岛素自主分泌的治疗方法。基于免疫抑制疗法以及胰岛分离和培养技术的改进,其成功率近来有所提高。众所周知,有活力的移植胰岛的质量和数量对于实现胰岛素自主分泌至关重要,并且一些研究表明在培养期间大量胰岛会丢失。因此,为了提高培养期间的胰岛产量,研究人员在培养基中测试了多种添加剂以及替代培养装置,如支架。然而,由于使用了不同类别的添加剂或装置,很难就这些策略的益处得出结论。因此,本系统综述的目的是总结描述在人胰岛培养过程中使用培养基添加剂、支架或细胞外基质(ECM)成分的研究结果。检索了PubMed和Embase数据库。在检索到的5083篇文章中,共有37篇文章符合纳入标准并被纳入综述。在数据提取后,文章被分为以下几类:1)“抗凋亡/抗炎/抗氧化剂”,2)“激素”,3)“磺脲类药物”,4)“血清补充剂”,5)“支架或ECM成分”。所综述的添加剂、ECM或支架对胰岛活力、凋亡和功能(葡萄糖刺激的胰岛素分泌 - GSIS)的影响是异质性的,难以得出任何主要结论。总体而言,一些“抗凋亡/抗炎/抗氧化剂”添加剂可减少凋亡并改善GSIS。此外,使用ECM成分或支架进行胰岛培养可提高GSIS。需要更多研究来确定这些策略对改善胰岛移植结果的实际影响。